Assessing Four Quality Indicators for Multiple Sclerosis Management Through Patient-Reported Data

Area of Science:

• Neurology
• Healthcare Quality
• Chronic Disease Management

Background:

• Quality indicators (QIs) for multiple sclerosis (MS) care are emerging.
• This study assesses patient-reported adherence to four new MS QIs.

Purpose of the Study:

• To evaluate how well individuals with MS meet specific quality indicators for their care.
• Focus on treatment of depression, spasticity, fatigue, and timely initiation of disease-modifying agents (DMAs).

Main Methods:

• Utilized Sonya Slifka Study data (2007-2009) from individuals with MS.
• Assessed patient-reported data against four defined MS QIs.
• Analyzed characteristics of individuals meeting QIs versus those who did not.

Main Results:

• Approximately two-thirds of participants met QIs for depression treatment, spasticity management, and timely DMA initiation.
• Only about one-fifth met the QI for fatigue management.
• Significant differences in characteristics were observed between those meeting and not meeting QIs.

Conclusions:

• Patient-reported data indicate partial adherence to newly developed MS QIs.
• Further research using diverse data sources is necessary for comprehensive QI compliance assessment.